Conceptio › Archive › IRIS
IRISmetadata only

Budget impact analysis of the subcutaneous infliximab (CT-P13 SC) for treating inflammatory bowel disease in the Big-5 European (E5) countries

Yoo, Hyun Kyeong et al.
IRIS · Papers
Open Source ↗
crohn-s-diseaseinflammatory-bowel-diseaseulcerative-colitis
budget impact, crohn’s disease, inflammatory bowel disease, ulcerative colitis, settore med/12 - gastroenterologia
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗
Record · ID 923136
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.